HCTI

Healthcare Triangle, Inc. (HCTI) - 10-Q Summary

Business Context and Reporting Period

This Quarterly Report on Form 10-Q covers the period ended June 30, 2026. Healthcare Triangle, Inc. is a healthcare information technology company that provides IT and data services to the Healthcare and Life Sciences industry. A significant strategic shift occurred on January 1, 2026, with the acquisition of Teyame 360 S.L. and Datono Mediacion S.L., creating a new "Customer Engagement Services" segment focused on AI-powered omnichannel customer experience and insurance distribution. The company is classified as a non-accelerated filer and a smaller reporting company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 158% year-over-year for the quarter (from $3.56M to $9.19M) and 167% for the six-month period. This growth is primarily driven by the new Customer Engagement Services segment, which contributed $6.31M in the quarter.
• Expense Expansion: General and Administrative (G&A) expenses surged 308% to $4.82M for the quarter, largely due to integration costs, professional fees, and transaction costs associated with the Teyame acquisition.
• Loss Widening: Net loss increased significantly to $4.42M for the quarter compared to $1.37M in the prior year quarter. This was exacerbated by a $652K loss from changes in fair value of convertible notes and increased depreciation/amortization ($529K) related to acquired intangible assets.
• Balance Sheet: Total assets grew from $22.7M to $73.6M, driven by the recognition of $54.8M in other intangible assets and $2.9M in goodwill from the acquisition. Cash reserves decreased from $7.6M to $1.9M due to acquisition payments and operating losses.

Guidance, Outlook, and Risks

Management Commentary: Management expects gross margins to continue increasing as new contracts are negotiated at higher rates. The company is focusing on integrating Teyame's AI capabilities to drive cross-selling opportunities and recurring revenue. A 1-for-60 reverse stock split was effected in February 2026.

Liquidity and Financing: Despite negative operating cash flows, management asserts sufficient liquidity for the next 12 months due to net assets of $49.1M and access to an Equity Line of Credit (ELOC) of up to $50M with Hudson Global Ventures. The company also maintains an At-the-Market (ATM) sales agreement.

Risks and Contingencies:

• Debt Obligations: The company carries significant debt, including $3.7M in 2026 Convertible Notes and $8.1M in debt from credit institutions (acquired via Teyame). Interest rates on these facilities range from 1.3% to 5.24%.
• Customer Concentration: The top five customers accounted for 55% of revenue in the quarter ended June 30, 2026.
• Integration Risk: Success depends on the effective integration of Teyame's operations and technology.
• Subsequent Events: Post-period, the company announced a non-binding letter of intent to acquire a 51% interest in CosmoAesthetics Pty Ltd for approximately $23.5M.

Investor Verification Checklist

• Acquisition Accounting: Verify the final purchase price allocation for the Teyame acquisition, as the initial accounting is provisional and subject to adjustment within one year.
• Debt Covenants: Review the specific covenants and maturity dates of the $8.1M in credit institution debt and the $3.7M in convertible notes to assess refinancing risks.
• Customer Retention: Monitor the retention rates of the new Customer Engagement Services customers, given the high concentration (55%) in the top five clients.
• ELOC Utilization: Track the utilization of the $50M Equity Line of Credit and the impact of potential dilution from future share issuances.
• Margin Sustainability: Validate management's projection of expanding gross margins against the high cost of revenue (78% of sales) in the current period.